External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis

External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis

Many trials confirmed the safety of omitting axillary dissection in the selected patients treated for early breast cancer. The external validity of these trials is questionable. Our study aimed to evaluate the accuracy of the French population representativity in the SERC trial and the differences b...

Full description

Bibliographic Details
Main Authors: Gilles Houvenaeghel, Houssein El Hajj, Julien Barrou, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, François Desmons, Agnès Tallet, Jean-Marie Boher, the SERC Trial Group
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
breast cancer
sentinel node
micro-metastases
trial
Online Access:https://www.mdpi.com/2072-6694/12/10/2924

Internet

https://www.mdpi.com/2072-6694/12/10/2924

Similar Items